R&D pharma executives clearly believe that digital technologies can help them accomplish their goal of improving patient outcomes, yet companies have been slow to embrace digital strategies and tools. Those that are lagging in digital adoption may run the risk of conceding competitive position, profit margin and even customer loyalty.
Pharmaceutical companies that have already adopted digital strategies self-report significantly stronger R&D capabilities in key areas. As example, they are far more advanced in core process redesign of Target Product Profile (TPP) and Clinical Development Plan (CDP), collaborating with other commercial organizations, harnessing real-world data analytics, and using digital to make more effective use of Medical Science Liaisons (MSLs).
Adoption of digital transformation to drive patient outcomes can help R&D organizations make the right decisions more quickly by improving data integration and analysis, as well as through better collaboration with and engagement of patients, providers, regulators and other stakeholders.
To assess your level of digital adoption, answer these five critical questions:
- Do you have a digital strategy that aligns with current company and R&D priorities?
- As an example, for each strategic goal, can you identify digital enablers that reflect the same scope, objective, competitive differentiation, and patient value.
- Have you mapped specific digital enablers to major clinical processes as well as to important stakeholders, such as investigators, patients, caregivers and vendors?
- Have you defined quantifiable value, ideal outcomes and experiences for investigators, patients, caregivers, and vendors? Then, have you thought broadly of how digital can complement your strategies to gain market growth in specific therapeutic areas, such as lifestyle diseases or most chronic illnesses, as well as customer segments, like non-mobile patients?
- For instance, therapeutic areas such as lifestyle diseases or most chronic illnesses, as well as customer segments like non-mobile patients, can provide the best opportunity to think broadly and differently about the strategy to engage patients to ensure improved outcomes.
- Are processes in place to enable stronger collaboration with other digital adoption stakeholders, such as the internal commercial organization as well as third parties?
- Are you fostering a digital culture and mindset by investing in or leveraging existing digital capabilities in R&D?
This could range from data analytic skills and working with Real World Evidence platforms to social media engagement.
[rss feed=”http://yoast.com/feed/” num=”5? excerpt=”true” target=”_blank”]